Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00127686 · ClinicalTrials.gov registry record · Phase 1

Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep

A Phase 1 study of Respiratory Tract Infections and Cough, sponsored by Penn State University.

Completed
Registry status
Phase 1
Development phase
105
Enrollment target
1
Study location

NCT00127686: Completed Phase 1 study of Respiratory Tract Infections and Cough, sponsored by Penn State University.

NCT00127686 is a Phase 1 study of Respiratory Tract Infections and Cough that has completed, run by Penn State University. The registered enrollment target is 105 participants, below the 2,767-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00127686, a Phase 1 study of Respiratory Tract Infections and Cough, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 1
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

Cough is the most common reason for an acute care doctor's visit in the United States. Cough can affect sleep for both coughing children and their parents. The American Academy of Pediatrics does not endorse the use of dextromethorphan (DM), the most common over-the-counter (OTC) cough medication because of a lack of efficacy data and some potential for toxicity, particularly when taken in excess. In fact, DM has previously been shown to be no better than a placebo for cough in children. Therefore, alternative, therapeutic agents are needed. Honey anecdotally provides relief for symptoms due to upper respiratory tract infection (URI). This study seeks to use a survey to evaluate whether a single dose of honey and/or DM is better than no treatment at all for controlling nocturnal cough in children with URI and the effect of the treatments on sleep quality for coughing children and their parents. A single dose of honey or DM will be superior to no treatment for control of nocturnal cough due to upper URI as rated by both parents and children and will improve the sleep quality for those children and parents. Compared to DM, honey will be superior for controlling nocturnal cough due to upper URI (also based on child and parental report).

Interventions

  • DRUG Dextromethorphan
  • DRUG Buckwheat Honey

Study Locations (1)

Pennsylvania

  • Penn State Milton S. Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2005-09
Est. Completion 2006-12
Phase Phase 1
Penn State University

219 total trials

What the finished NCT00127686 record still lists

NCT00127686 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 2,767-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Respiratory Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Dextromethorphan is the first listed.

NCT00127686 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00127686 about?

NCT00127686 is a clinical study titled "Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep". Cough is the most common reason for an acute care doctor's visit in the United States. Cough can affect sleep for both coughing children and their parents. The American Academy of Pediatrics does not endorse the use of dextromethorphan (DM), the most common over-the-counter (OTC) cough medication be...

What is the current status of trial NCT00127686?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 105 participants. The study started on 2005-09. Estimated completion is 2006-12.

What conditions does trial NCT00127686 study?

This clinical trial studies the following conditions: Respiratory Tract Infections, Cough.

What interventions are being tested in trial NCT00127686?

The interventions under investigation include: Dextromethorphan (DRUG), Buckwheat Honey (DRUG).

Who is sponsoring clinical trial NCT00127686?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00127686 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Tract Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00127686's enrollment target sits among peer trials

105 12th of 15 higher than 4 of 15 other Respiratory Tract Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00127686, the US trial registry maintained by the National Library of Medicine. NCT00127686 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.